NASDAQ$AIP
Arteris Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Reported a revenue increase and positive free cash flow for the second consecutive quarter.
Arteris reported Q2 2024 financial results with a revenue of $14.6 million, up 13% sequentially. The company achieved a record $60.1 million in Annual Contract Value and Trailing-Twelve-Month Variable Royalties and reported its second consecutive quarter of positive free cash flow.
- Revenue reached $14.6 million, a 13% sequential increase.
- Annual Contract Value and trailing-twelve-months variable royalties reached $60.1 million, up 3% year-over-year.
- Remaining performance obligation (RPO) reached $77.5 million, up 19% year-over-year.
- Non-GAAP free cash flow was positive $0.3 million, representing 1.8% of revenue.
Headline financials
Revenue & EPS history
Arteris · Revenue · Quarterly
$14.6M
Revenue by segment
Arteris · $12.6M total across 2 segments · Q3 2022
- Licensing, support and maintenance$11.1M+36.9%88.4%
- Variable royalties and other$1.46M+77.8%11.6%
Forward guidance
Arteris provided guidance for Q3 2024 and full year 2024.
Tailwinds
- Q3 2024 ACV + TTM royalties are expected to be between $58.5 million and $62.5 million.
- Full year 2024 ACV + TTM royalties are expected to be between $62.0 million and $68.0 million.
- Q3 2024 revenue is projected to be between $14.2 million and $15.2 million.
- Full year 2024 revenue is projected to be between $56.0 million and $58.0 million.
- Q3 2024 Free cash flow is expected to be between $(1.4) million and $1.6 million.
Headwinds
- Q3 2024 Non-GAAP operating loss is expected to be between $3.5 million and $5.5 million.
- Full year 2024 Non-GAAP operating loss is expected to be between $18.0 million and $22.0 million.
- Full year 2024 Free cash flow is expected to be between $(2.4) million and $(2.6) million.
- Guidance are forward-looking statements and reflects Arteris' expectations as of today's date.
- Actual results may differ materially.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q2 2024
-1.5%
Avg return
Earnings day
-2.0%
Avg return
5 days after
+0.6%
Avg return
30 days after
27%
6 / 22 earnings
Positive
+31.4%
Q1 2024
Best reaction
-25.1%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +9.4% | +2.7% | +26.6% | |
| Q4 2025 | -2.0% | -3.6% | -1.9% | |
| Q3 2025 | +26.0% | +21.3% | +42.5% | |
| Q1 2025 | -10.2% | -10.1% | -4.9% | |
| Q4 2024 | -1.5% | -8.1% | -22.4% | |
| Q3 2024 | +25.6% | +22.7% | +31.0% | |
| Q2 2024 | -8.7% | -18.2% | +4.8% | |
| Q1 2024 | +31.4% | +41.1% | +30.7% | |
| Q4 2023 | -7.5% | -11.2% | -1.8% | |
| Q3 2023 | -25.1% | -31.8% | -12.4% | |
| Q2 2023 | +0.1% | -1.3% | -0.1% | |
| Q1 2023 | +17.5% | +17.0% | +77.9% | |
| Q4 2022 | -16.9% | -21.5% | -37.7% | |
| Q3 2022 | -7.4% | +9.0% | -18.6% | |
| Q2 2022 | -2.5% | -5.8% | -17.4% | |
| Q1 2021 | -3.6% | +2.1% | -2.0% | |
| Q1 2022 | -3.6% | +2.1% | -2.0% | |
| Q2 2021 | -8.4% | -6.1% | -3.6% | |
| Q4 2021 | -8.3% | -16.0% | -10.9% | |
| Q3 2020 | -12.1% | -10.1% | -22.3% | |
| Q4 2020 | -12.1% | -10.1% | -22.3% | |
| Q3 2021 | -13.7% | -7.4% | -20.1% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro